NHF Cardholders to Benefit from New Drugs
New for the treatment of Breast Cancer are Faslodex Injection with the active ingredient Fulvestrant for which NHF offers a subsidy of close to $40,000 per 250mg injection and Gemcit Injection with the active ingredient gemcitabine hydrochloride with a subsidy of $2,000 per 200mg injection and $10,400 per 1g injection.
Reditux Injection with the active ingredient Rituximab with a subsidy of $13,300 per 100mg injection and $66,100 per 500mg injection has been added for the treatment of Arthritis.
These changes came into effect October 12 this year.
A complete drug list and subsidies paid by the NHF are available from NHF participating Pharmacies, the NHF website or by calling NHF at 1-888-NHF-CARE.